Back
Neurocrine Biosciences Stock Price Chart
Buy
60
NBIX
Neurocrine Biosciences
Last Price:
142.31
Seasonality Move:
6.24%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Neurocrine Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 139.52 | Buy |
| 20-day SMA: | 139.38 | Buy |
| 50-day SMA: | 138.59 | Buy |
| 200-day SMA: | 124.43 | Buy |
| 8-day EMA: | 140.43 | Buy |
| 20-day EMA: | 139.35 | Buy |
| 50-day EMA: | 137.87 | Buy |
| 200-day EMA: | 126.71 | Buy |
Neurocrine Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.97 | Buy |
| Relative Strength Index (14 RSI): | 57.07 | Buy |
| Chaikin Money Flow: | 329489 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (134.45 - 141.57) | Buy |
| Bollinger Bands (100): | (133.08 - 140.72) | Buy |
Neurocrine Biosciences Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurocrine Biosciences Stock
Is Neurocrine Biosciences Stock a Buy?
- Neurocrine Biosciences share price is 142.29 while NBIX 8-day simple moving average is 139.52, which is a Buy signal.
- The stock price of NBIX is 142.29 while Neurocrine Biosciences 20-day SMA is 139.38, which makes it a Buy.
- Neurocrine Biosciences 50-day simple moving average is 138.59 while NBIX share price is 142.29, making it a Buy technically.
- NBIX stock price is 142.29 and Neurocrine Biosciences 200-day simple moving average is 124.43, creating a Buy signal.
NBIX Technical Analysis vs Fundamental Analysis
Buy
60
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy or a Sell?
-
Neurocrine Biosciences stock is rated a Buy
The current Neurocrine Biosciences [NBIX] share price is $142.29. The Score for NBIX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Neurocrine Biosciences Stock Info
Market Cap:
14.32B
Price in USD:
142.29
Share Volume:
639.92K
Neurocrine Biosciences 52-Week Range
52-Week High:
148.37
52-Week Low:
89.04
Buy
60
Neurocrine Biosciences (NBIX)
is a Buy
Neurocrine Biosciences Share Price Forecast
-
What is the Neurocrine Biosciences stock price today?
The Neurocrine Biosciences stock price is 142.29 USD today. -
Will NBIX stock go up or go down?
Neurocrine Biosciences> share price is forecast to RISE/FALL based on technical indicators -
Is Neurocrine Biosciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences is not overvalued.
Is Neurocrine Biosciences Stock a Buy?
- Neurocrine Biosciences share price is 142.29 while NBIX 8-day exponential moving average is 140.43, which is a Buy signal.
- The stock price of NBIX is 142.29 while Neurocrine Biosciences 20-day EMA is 139.35, which makes it a Buy.
- Neurocrine Biosciences 50-day exponential moving average is 137.87 while NBIX share price is 142.29, making it a Buy technically.
- NBIX stock price is 142.29 and Neurocrine Biosciences 200-day simple moving average is 126.71, creating a Buy signal.
Fundamental Analysis of Neurocrine Biosciences
Is Neurocrine Biosciences a good investment?
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.04 per share, an increase this year of $1.88 per share, and an increase next year of $1.37 per share.
Technical Analysis of Neurocrine Biosciences
Should I short Neurocrine Biosciences stock?
- NBIX Moving Average Covergence Divergence (MACD) indicator is 0.97, suggesting Neurocrine Biosciences is a Buy
- Neurocrine Biosciences Relative Strength Index (RSI) is 57.07, which suggest Neurocrine Biosciences is overbought
- The Bollinger Bands (25) for Neurocrine Biosciences is (134.45 - 141.57), which suggest Neurocrine Biosciences is a Buy
- The Bollinger Bands (100) for Neurocrine Biosciences is (133.08 - 140.72), which suggest Neurocrine Biosciences is a Buy
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.